Metformin Increases Survival in Hypopharyngeal Cancer Patients with Diabetes Mellitus: Retrospective Cohort Study and Cell-Based Analysis

Hypopharyngeal squamous cell carcinoma (HSCC) is usually diagnosed at an advanced stage, leading to a poor prognosis. Even after improvement of surgical techniques, chemotherapy, and radiation technology, the survival rate of HSCC remains poor. Metformin, which is commonly used for type 2 diabetes m...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsou, Yung-An, Chang, Wei-Chao, Lin, Chia-Der, Chang, Ro-Lin, Tsai, Ming-Hsui, Shih, Liang-Chun, Staniczek, Theresa, Wu, Tsu-Fang, Hsu, Hui-Ying, Chang, Wen-Dien, Lai, Chih-Ho, Chen, Chuan-Mu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996771/
https://www.ncbi.nlm.nih.gov/pubmed/33652909
http://dx.doi.org/10.3390/ph14030191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996771/
https://www.ncbi.nlm.nih.gov/pubmed/33652909
http://dx.doi.org/10.3390/ph14030191

Ejemplares similares